News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Federico Pio Fabrizio: The intersection of epigenetics and immunotherapy
Federico Pio Fabrizio/X
Feb 19, 2025, 10:26

Federico Pio Fabrizio: The intersection of epigenetics and immunotherapy

Federico Pio Fabrizio, Associate Professor in Molecular Biology at The Kore University of Enna, posted on LinkedIn.

“I’m glad to announce this Collection on Epigenetics and Cancer Immunotherapy in Clinical Epigenetics Springer Nature journal (Q1 Molecular Biology) edited by me and Dr. Mariarosaria Conte.

We discuss the intersection of epigenetics and immunotherapy, which extends to intriguing insights regarding immune regulation, biomarkers discovery, and novel therapeutic agents.

Original research articles and reviews are welcome!”

Read Further.

BMC cancer Epigenetics and Cancer Immunotherapy in Clinical Epigenetics Federico Pio Fabrizio Mariarosaria Conte OncoDaily Oncology Springer Nature
Special Coverage
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care
Blog
Feb 20, 2025, 10:52
Rob Winn: Our partners are what make the miracle medicines possible
Blog
Feb 20, 2025, 10:48
World Cancer Research Fund International's new policy blueprint to help policymakers reduce cancer risks - UICC
Blog
Feb 20, 2025, 10:45
Evaluating molecularly guided therapies beyond tumor type - ESMO
Blog
Feb 20, 2025, 10:41
Rasha Aboelhassan: Screening access is further limited by age and tobacco use history, which often excludes woman